Reuters logo
BRIEF-TG Therapeutics posts results from long-term follow-up of TGR-1202
2016年6月6日 / 下午1点27分 / 1 年前

BRIEF-TG Therapeutics posts results from long-term follow-up of TGR-1202

June 6 (Reuters) - Tg Therapeutics Inc

* Term follow-up of TGR-1202 demonstrates a differentiated safety profile and high response rates in CLL and NHL Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below